Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. active covid-19 infection by pcr testing 2. pre-existing igg or igm sars-cov-2 antibodies 3. pregnant, known hypersensitivity to gm-csf 4. known active immune deficiency disease or active hiv 5. hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent 6. participated in previous covid-19 vaccine study

1. active covid-19 infection by pcr testing 2. pre-existing igg or igm sars-cov-2 antibodies 3. pregnant, known hypersensitivity to gm-csf 4. known active immune deficiency disease or active hiv 5. hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent 6. participated in previous covid-19 vaccine study

Nov. 16, 2021, 6:30 p.m. usa

active covid-19 infection by pcr testing pre-existing igg or igm sars-cov-2 antibodies pregnant, known hypersensitivity to gm-csf known active immune deficiency disease or active hiv hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent participated in previous covid-19 vaccine study

active covid-19 infection by pcr testing pre-existing igg or igm sars-cov-2 antibodies pregnant, known hypersensitivity to gm-csf known active immune deficiency disease or active hiv hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent participated in previous covid-19 vaccine study

Dec. 30, 2020, 12:31 a.m. usa

1. active covid-19 infection by pcr testing 2. pre-existing igg or igm sars-cov-2 antibodies 3. pregnant, known hypersensitivity to gm-csf 4. known active immune deficiency disease or active hiv 5. hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent 6. participated in previous covid-19 vaccine study

1. active covid-19 infection by pcr testing 2. pre-existing igg or igm sars-cov-2 antibodies 3. pregnant, known hypersensitivity to gm-csf 4. known active immune deficiency disease or active hiv 5. hbv, hcv, on active treatment with corticosteroids or other immunosuppressive agent 6. participated in previous covid-19 vaccine study